Works matching IS 0031711X AND DT 2017 AND VI 79 AND IP 2

Results: 49
    1
    2

    Aktivitäten des COMP.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 236
    By:
    • Throm, Siegfried
    Publication type:
    Article
    3
    4

    Ritual ohne Folgen.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 155
    By:
    • Postina, Thomas
    Publication type:
    Article
    5
    6
    7
    8

    Die „Rote Königin“.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 159
    By:
    • Reitz, Manfred
    Publication type:
    Article
    9
    10

    Aktivitäten des PDCO.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 239
    By:
    • Throm, Siegfried
    Publication type:
    Article
    11

    Aktivitäten des PRAC.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 242
    By:
    • Thurisch, Boris;
    • Sickmüller, Barbara
    Publication type:
    Article
    12
    13

    Aktuelles aus G-BA und IQWiG.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 182
    By:
    • Marquardt, Britta;
    • Wilken, Matthias
    Publication type:
    Article
    14
    15
    16
    17
    18

    Qualifizierungsmasterplan.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 269
    By:
    • Peither, Thomas
    Publication type:
    Article
    19
    20

    GMP- und GDP-Update: 22. GMPKonferenz.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 261
    By:
    • Allhenn, Daniela;
    • Wollersen, Heike;
    • Anhalt, Ehrhard;
    • Schnettler, Reinhard
    Publication type:
    Article
    21
    22

    Noroviren.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 280
    By:
    • Beckmann, Gero
    Publication type:
    Article
    23

    Bayer Pharmaceuticals.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 176
    Publication type:
    Article
    24

    AstraZeneca Deutschland.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 176
    Publication type:
    Article
    25

    Biogen Deutschland.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 176
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32

    Spritzenzuführung.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 297
    Publication type:
    Article
    33

    Toploading Kartonierer.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 297
    Publication type:
    Article
    34
    35

    Reindampfventile.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 299
    Publication type:
    Article
    36
    37

    Filtrationssystem.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 298
    Publication type:
    Article
    38

    Haftkleber.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 298
    Publication type:
    Article
    39

    Klarglasfläschchen.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 300
    Publication type:
    Article
    40

    Partikelanalysatoren.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 296
    Publication type:
    Article
    41
    42
    43

    Kühltransporte.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 300
    Publication type:
    Article
    44

    Spritze.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 298
    Publication type:
    Article
    45
    46
    47

    Pharmafläschchen.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 301
    Publication type:
    Article
    48

    Verpackungsdrucker.

    Published in:
    Pharmazeutische Industrie (Pharmind), 2017, v. 79, n. 2, p. 301
    Publication type:
    Article
    49